Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How do you manage HPV positive squamous cell carcinoma in situ of the oropharynx?
Answer from: Radiation Oncologist at Academic Institution
transoral surgery
Sign In
or
Register
to read more
3210
Related Questions
How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?
How would you approach post-op radiation recommendations in patients who had neoadjuvant chemoimmunotherapy for HPV mediated OPSCC s/p TORS who have a complete pathologic response (pCR)?
What is your recommendation for patients who are on weight loss medications like GLP-1-based therapies while receiving chemoradiation for head and neck cancer?
For a patient s/p TORS with indications for adjuvant radiation, how does your management change with persistently elevated ctHPVDNA?
How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?
How would you manage a presumed radiation induced sarcoma of the head and neck?
What alternatives do you recommend for oral dexamethasone solution for HN cancer?
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?
What is the preferred neoadjuvant/adjuvant chemotherapy regimen for HPV-associated nasopharyngeal cancer?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?